HCID 178458066, compound → HCID 178457504, compound
Reaction equation
[N:1]([C:4]([C@H:7]1[CH2:12][CH2:11][C@H:10]([NH:13][C:14]2[CH:15]=[CH:16][C:17]3[N:18]([C:20]([C:23]4[CH:28]=[CH:27][CH:26]=[C:25]([Cl:29])[CH:24]=4)=[CH:21][N:22]=3)[N:19]=2)[CH2:9][CH2:8]1)([CH3:6])[CH3:5])=[N+]=[N-]>CO.C(Cl)Cl.[Pd]>[NH2:1][C:4]([C@H:7]1[CH2:12][CH2:11][C@H:10]([NH:13][C:14]2[CH:15]=[CH:16][C:17]3[N:18]([C:20]([C:23]4[CH:28]=[CH:27][CH:26]=[C:25]([Cl:29])[CH:24]=4)=[CH:21][N:22]=3)[N:19]=2)[CH2:9][CH2:8]1)([CH3:6])[CH3:5]Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Procedure
A mixture of N-(trans-4-(2-azidopropan-2-yl)cyclohexyl)-3-(3-chlorophenyl)imidazo[1,2-b]pyridazin-6-amine (90 mg, 0.22 mmol) and Pd/C (30 mg) in MeOH (5 mL) and CH2Cl2 (5 mL) was hydrogenated under 50 psi of H2 at room temperature for 48 h. LCMS showed the reaction was complete. The mixture was filtered and the filtrate was concentrated in vacuo. The residue was purified by prep. HPLC to give EX. 8-79 (4 mg, 5%) as an off-white solid.
Workup
- filtrationThe mixture was filtered
- concentrationthe filtrate was concentrated in vacuo
- customThe residue was purified by prep
- customHPLC to give EX
Sources & evidence
- ORD record
- ord-52d1b7ec39d440eb955fa0ba05bb0f57
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09416132B2
Reaction notes
Loading…